CAR T-cell Therapy at Higher Dose Might Treat Advanced Neuroblastoma, Early Trial Results Suggest – Immuno-Oncology News
Immuno-Oncology News |
CAR T-cell Therapy at Higher Dose Might Treat Advanced Neuroblastoma, Early Trial Results Suggest
Immuno-Oncology News In this first clinical study in patients (NCT02761915), researchers are investigating the safety and the potential of a chimeric antigen receptor (CAR)-T cell therapy targeting the disialoganglioside (GD2) protein to treat relapsed or refractory … |
